THIOURIC ACID
Title | Journal |
---|---|
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II). | Toxicology and applied pharmacology 20180620 |
Study of drug metabolism by xanthine oxidase. | International journal of molecular sciences 20120101 |
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines. | BMC cancer 20110101 |
State-of-the-art: Immunosuppression and biologic therapy. | Digestive diseases (Basel, Switzerland) 20100101 |
The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia--an exploratory study. | European journal of clinical pharmacology 20091101 |
Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease. | Alimentary pharmacology & therapeutics 20080915 |
The role of xanthine oxidase in thiopurine metabolism: a case report. | Therapeutic drug monitoring 20071201 |
In vitro study of 6-mercaptopurine oxidation catalysed by aldehyde oxidase and xanthine oxidase. | Drug metabolism and pharmacokinetics 20070801 |
Application of HPLC to study the kinetics of a branched bi-enzyme system consisting of hypoxanthine-guanine phosphoribosyltransferase and xanthine oxidase--an important biochemical system to evaluate the efficiency of the anticancer drug 6-mercaptopurine in ALL cell line. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501 |
Nature and position of functional group on thiopurine substrates influence activity of xanthine oxidase--enzymatic reaction pathways of 6-mercaptopurine and 2-mercaptopurine are different. | Biochemistry. Biokhimiia 20070201 |
Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol. | BMC biochemistry 20070101 |
Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells. | BMC cancer 20060101 |
HPLC analysis of azathioprine metabolites in red blood cells, plasma and urine in renal transplant recipients. | International journal of clinical pharmacology and therapeutics 19951201 |